Literature DB >> 650005

The nephrotoxicity of cephalosporins: an overview.

M Barza.   

Abstract

The cephalosporin antibiotics cephaloridine and cephalothin are known to cause renal damage. Experience with newer congeners is not yet sufficient to predict their potential nephrotoxocity. The renal lesion produced by cephaloridine is primarily due to the intrinsic toxicity of this drug for the cells of the proximal renal tubule and depends upon its peculiar transport characteristics. In contrast, renal injury due to cephalothin resembles that seen with the penicillins. Thus, some instances of cephalothin nephropathy appear to be toxic in nature with a histologic picture of acute tubular necrosis, whereas others exhibit signs of hypersensitivity including rash, eosinophilia, and interstitial nephritis. Among the factors alleged to contribute to the nephrotoxicity of cephalosporins is their administration with aminoglycosides. Although the physician should be aware of the possibility of a potential adverse interaction between these groups of antibiotics, the evidence is not sufficiently conclusive to warrant avoidance of the combination when it appears to be therapeutically useful.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 650005     DOI: 10.1093/infdis/137.supplement.s60

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

2.  Acute interstitial nephritis and non-oliguric renal failure after cefaclor treatment.

Authors:  W Pommer; P H Krause; P A Berg; H H Neumayer; M J Mihatsch; M Molzahn
Journal:  Klin Wochenschr       Date:  1986-03-17

3.  Clinical pharmacokinetics and safety of high doses of ceforanide (BL-S786R) and cefazolin.

Authors:  R D Smyth; M Pfeffer; A Glick; D R Van Harken; G H Hottendorf
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

4.  An in vitro approach to the study of target organ toxicity of drugs and chemicals.

Authors:  D Acosta; E M Sorensen; D C Anuforo; D B Mitchell; K Ramos; K S Santone; M A Smith
Journal:  In Vitro Cell Dev Biol       Date:  1985-09

Review 5.  Side effects of cephalosporins.

Authors:  S R Norrby
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 6.  Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  E Saltiel; R N Brogden
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

7.  Renal tolerance of cefpirome (HR 810), a new cephalosporin antibiotic.

Authors:  M Verho; L Maass; V Malerczyk; H Grötsch
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

8.  Assessment of the nephrotoxic potential of ceftazidime and a ceftazidime/tobramycin combination in volunteers.

Authors:  A W Mondorf; F T Heynold; J E Scherberich; H Hess; W Schoeppe
Journal:  Infection       Date:  1983       Impact factor: 3.553

9.  Nephrotoxicity of cefotiam (CGP 14221/E) in rats and rabbits.

Authors:  E D Wachsmuth
Journal:  Arch Toxicol       Date:  1981-09       Impact factor: 5.153

10.  Suggested guidelines for using systemic antimicrobials in bacterial skin infections: part 2-- antimicrobial choice, treatment regimens and compliance.

Authors:  L Beco; E Guaguère; C Lorente Méndez; C Noli; T Nuttall; M Vroom
Journal:  Vet Rec       Date:  2013-02-09       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.